Bharat Parenterals (BOM:541096) Construction In Progress: ₹339 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:541096 Bharat Parenterals Ltd BOM:541096
74 GF Score
Price ₹1,375.00
GF Value ₹1,158.85
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Bharat Parenterals Construction In Progress?

Bharat Parenterals BOM:541096 -3.12% 74 Construction In Progress is ₹339 Mil as of Mar. 2026. GuruFocus rates BOM:541096 with a GF Score™ of 74/100 and a GF Value™ of ₹1,158.85 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Bharat Parenterals's quarterly construction in progress declined from Sep. 2025 (₹303 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹339 Mil).

Bharat Parenterals's annual construction in progress increased from Mar. 2024 (₹283 Mil) to Mar. 2025 (₹371 Mil) but then declined from Mar. 2025 (₹371 Mil) to Mar. 2026 (₹339 Mil).

Bharat Parenterals Construction In Progress Historical Data

* Premium members only.

The historical data trend for Bharat Parenterals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Parenterals Construction In Progress Chart

Bharat Parenterals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 256.54 1,196.74 282.88 371.33 339.49

Bharat Parenterals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 371.33 0.00 302.90 0.00 339.49
BOM:541096
74GF Score
Bharat Parenterals Ltd BOM:541096
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bharat Parenterals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹339 Mil mean?
Bharat Parenterals (BOM:541096) has a Construction In Progress of ₹339 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Bharat Parenterals and its competitors.
Is Bharat Parenterals' Construction In Progress too high?
Bharat Parenterals' current Construction In Progress is ₹339 Mil. Overall, Bharat Parenterals has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bharat Parenterals' Construction In Progress compare to ZTS?
Bharat Parenterals' Construction In Progress of ₹339 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Bharat Parenterals and its competitors. Bharat Parenterals's current Construction In Progress is ₹339 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Parenterals stock overvalued right now?
Based on GuruFocus' analysis, Bharat Parenterals (BOM:541096) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,158.85, compared to a current price of ₹1,375.00 — trading 18.7% above its estimated fair value. The current Construction In Progress is ₹339 Mil. Bharat Parenterals' overall GF Score™ is 74/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Bharat Parenterals (BOM:541096), the current Construction In Progress is ₹339 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bharat Parenterals (BOM:541096) Overvalued in 2026?

Based on GuruFocus' analysis, Bharat Parenterals stock appears to be overvalued. The current stock price of ₹1,375.00 is trading 18.7% above its estimated GF Value™ of ₹1,158.85. GuruFocus considers Bharat Parenterals to be Modestly Overvalued.

Key valuation signals for BOM:541096:

  • Construction In Progress: ₹339 Mil
  • GF Value™: ₹1,158.85 vs. price of ₹1,375.00 (18.7% above fair value)
  • GF Score™: 74/100 with 8 warning signs

No single metric tells the full story. See the BOM:541096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bharat Parenterals Business Description

Address Survey No.144-A, Jarod Samlaya Road, Village Haripura, Tehsil Savli, Vadodara, GJ, IND, 391520
Bharat Parenterals Ltd is a pharmaceutical company. It provides various products such as Capsules, Dry Syrups, Sachets, Oral Liquids, Injections, Semisolids, and others. Geographically, the group has a business presence in India and Outside India.
74GF Score

Get the complete analysis for BOM:541096

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,375.00
Price
₹1,158.85
GF Value